About Pricing FAQs Providers Trials Blog

Back to your record

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

The Effects of Discontinuation of Vitamin K Antagonists on the Rate of Elastin Degradation

NCT03285100·1 site·ClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Rob Janssen, MD, PhD
CONTACT
+31-24-3658755 rob.janssen@cwz.nl
Ianthe Piscaer, MD
CONTACT
+31-43-3875051 ianthe.piscaer@mumc.nl

Lead

Canisius-Wilhelmina Hospital

With

Maastricht University Medical Center

Age

18–any

Sex

ALL

Healthy volunteers

Not accepted

You may be eligible if

Use of VKAs for at least 3 months
Stop VKAs at short time
Written informed consent
Age ≥18 years
Ability to comply with all study requirements

You may not be if

Active malignancy or cured malignancy \<12 months prior to enrollment
Use of maintenance dose oral corticosteroids
Serious mental impairment
Life expectation of less than 6 months on the basis of concurrent disease

The record

StatusUnknown

PhaseNo phase

Taking part30

StartedOct 2017

UpdatedJan 25, 2018

Conditions

Emphysema or COPD Aneurysm Cystic Fibrosis Alpha 1-Antitrypsin Deficiency

Where1

Canisius Wilhelmina Hospital
Nijmegen, Netherlands